4.6 Article

Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period

Journal

PLOS ONE
Volume 15, Issue 5, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0232786

Keywords

-

Funding

  1. National Research Council for Scientific and Technological Development-CNPq [422257/2016-8]
  2. Research Foundation of Minas Gerais-FAPEMIG [APQ-02625-15]
  3. Programa Fiocruz de Fomento a Inovacao: Inova Fiocruz [VPPCB-007FIO-18-2-33]
  4. NIH Research Project Grant Program [R01AI064478]
  5. Coordination for the Improvement of Higher Education Personnel-CAPES (BASL)
  6. Coordination for the Improvement of Higher Education Personnel-CAPES (JRSA)
  7. Coordination for the Improvement of Higher Education Personnel-CAPES (LFFG)
  8. Coordination for the Improvement of Higher Education Personnel-CAPES (LMT)
  9. CNPq (CMPM)
  10. CNPq (HLC)
  11. CNPq (CVP)
  12. CNPq (EUMM)
  13. Program for Institutional Internationalization of the Higher Education Institutions
  14. Research Institutions of Brazil-CAPES-PrInt from FIOCRUZ
  15. UFMG

Ask authors/readers for more resources

Background A low proportion of P. vivax-exposed individuals acquire protective strain-transcending neutralizing IgG antibodies that are able to block the interaction between the Duffy binding protein II (DBPII) and its erythrocyte-specific invasion receptor. In a recent study, a novel surface-engineered DBPII-based vaccine termed DEKnull-2, whose antibody response target conserved DBPII epitopes, was able to induce broadly binding-inhibitory IgG antibodies (BIAbs) that inhibit P. vivax reticulocyte invasion. Toward the development of DEKnull-2 as an effective P. vivax blood-stage vaccine, we investigate the relationship between naturally acquired DBPII-specific IgM response and the profile of IgG antibodies/BIAbs activity over time. Methodology/principal findings A nine-year follow-up study was carried-out among long-term P. vivax-exposed Amazonian individuals and included six cross-sectional surveys at periods of high and low malaria transmission. DBPII immune responses associated with either strain-specific (Sal1, natural DBPII variant circulating in the study area) or conserved epitopes (DEKnull-2) were monitored by conventional serology (ELISA-detected IgM and IgG antibodies), with IgG BIAbs activity evaluated by functional assays (in vitro inhibition of DBPII-erythrocyte binding). The results showed a tendency of IgM antibodies toward Sal1-specific response; the profile of Sal1 over DEKnull-2 was not associated with acute malaria and sustained throughout the observation period. The low malaria incidence in two consecutive years allowed us to demonstrate that variant-specific IgG (but not IgM) antibodies waned over time, which resulted in IgG skewed to the DEKnull-2 response. A persistent DBPII-specific IgM response was not associated with the presence (or absence) of broadly neutralizing IgG antibody response. Conclusions/significance The current study demonstrates that long-term exposure to low and unstable levels of P. vivax transmission led to a sustained DBPII-specific IgM response against variant-specific epitopes, while sustained IgG responses are skewed to conserved epitopes. Further studies should investigate on the role of a stable and persistent IgM antibody response in the immune response mediated by DBPII.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available